1.
Krakchemia S.A. - Homopolimery
Moplen HP 540 J, fetch the file » · fetch the file » · fetch the file ». Moplen HP 548 N, fetch the file ». Moplen HP 555 E, fetch the file » · fetch the ...
2.
KRASTEN 562 E
File Format: PDF/Adobe Acrobat - View as HTML KRASTEN 562 E is suitable for extrusion processing and designed for the production of plates and sheets, which are later thermoformed to make packaging ...
3.
Krakchemia S.A. Kwas siarkowy
- [ Translate this page ]Kwas siarkowy min 95%, czda, 30 l. Kwas siarkowy 95%, czda, 1 l ... Kwas siarkowy 95%, cz, 1 l. Kwas siarkowy 91%, cz, 1 l. Kwas siarkowy 91%, cz, 5 l ...
4.
Krakchemia S.A. - Listwy aluminiowe
Aluminium skirtings. Floor finishing skirtings · Stair skirtings · Connecting threshold skirting · Quarter round. Copyright 2008 Krakchemia S.A. ...
5.
KoleKcja Bieli i czerni Pl
File Format: PDF/Adobe Acrobat - View as HTML COLEX Spółka z o.o. 95-100 Zgierz, ul. Kolorowa 14 tel.: (+48 42) 716 24 50, 716 24 98; fax: (+48 42) 716 13 25 office@colex.com.pl www.colex.com.pl ...
6.
Środki pomocnicze PL
File Format: PDF/Adobe Acrobat - View as HTML COLEX Spółka z o.o. 95-100 Zgierz, ul. Kolorowa 14 tel.: (+48 42) 716 24 50, .... COLEX Spółka z o.o.. AddiTiVeS For pLASTicS. EN recommended application ...
7.
Środki pomocnicze PL
File Format: PDF/Adobe Acrobat - View as HTML COLEX Spółka z o.o. 95-100 Zgierz, ul. Kolorowa 14 tel.: (+48 42) 716 24 50, .... COLEX Spółka z o.o.. AddiTiVeS For pLASTicS. EN recommended application ...
8.
Krakchemia S.A. - Home
The Board of Krakchemia S.A. informs that on the day of 5 January 2007, Krakchemia concluded the preliminary conditional contract concerning the purchase of ...
9.
Krakchemia S.A. - Homopolimery
The Board of Krakchemia S.A. informs that on the day of 5 January 2007, Krakchemia concluded the preliminary conditional contract concerning the purchase of ...
10.
Moplen HP400H
File Format: PDF/Adobe Acrobat - View as HTML The base resin in Moplen HP400H meets the FDA (Food and Drug ... in Moplen HP400H meet the requirements of their respective FDA ...